Fast Market Research recommends "Generics in France" from MarketLine, now available

Boston, MA -- (SBWire) -- 09/25/2013 --Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The French generics market had total revenues of $4.5bn in 2012, representing a compound annual growth rate (CAGR) of 7.2% between 2008 and 2012.
- Market consumption volume increased with a CAGR of 10.1% between 2008-2012, to reach a total of 42.7% of total pharma volume in 2012.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 5.2% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $5.8bn by the end of 2017.

View Full Report Details and Table of Contents

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in France

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France

Leading company profiles reveal details of key generics market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the France economy

Key Questions Answered

What was the size of the France generics market by value in 2012?

What will be the size of the France generics market in 2017?

What factors are affecting the strength of competition in the France generics market?

How has the market performed over the last five years?

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Generics: Global Industry Guide
- PharmaSphere: Global Generics Strategy - Key Drivers, Markets and Trends in 2013
- The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
- Generics in Spain
- Generics in Germany
- Generics in Canada
- Generics in China
- Generics in the Netherlands
- Generics in the United States
- Generics in Japan